European Cannabis Company EMMAC To Trade On NASDAQ

European Cannabis Company EMMAC To Trade On NASDAQ

Europe’s largest independent cannabis company EMMAC Life Sciences Limited will become a publicly-traded company on the NASDAQ following a merger with Andina Acquisition Corp. III (NASDAQ: ANDA). The two companies signed a non-binding letter of intent (LOI) to combine with EMMAC’s shareholders rolling over all of their equity in EMMAC into the combined public company and becoming the majority owner of the combined company.

READ MORE
Cannabis company Emmac to go public with Andina deal

Cannabis company Emmac to go public with Andina deal

UK medical cannabis startup Emmac Life Sciences is set to go public by merging with Andina Acquisition Corp III. The two parties have signed a non-binding letter of intent for a deal that will see Emmac floated on the Nasdaq exchange. Emmac's previous VC backers include Altitude Investment Management, Fountain Healthcare and Measure 8 Venture Partners.

READ MORE
European Pot Firm Emmac Agrees to Go Public Via Andina

European Pot Firm Emmac Agrees to Go Public Via Andina

European marijuana firm Emmac Life Sciences Ltd. has agreed to go public through a merger with Andina Acquisition Corp. III. The companies have signed a non-binding letter of intent for a combination in which Emmac would be listed on the Nasdaq stock market, according to a statement Wednesday confirming an earlier Bloomberg News report. The terms of the transaction weren’t disclosed.

READ MORE
INTERVIEW: European Cannabis Leader EMMAC Gets Lifted Through a SPAC

INTERVIEW: European Cannabis Leader EMMAC Gets Lifted Through a SPAC

EMMAC Life Sciences, Europe’s largest cannabis company, will go public through a merger with Andina Acquistion Corp. III, giving U.S. investors access to the white-hot medical cannabis sector in Europe. EMMAC signed a letter of intent to combine with the special purpose acquisition company, or SPAC, to publicly trade on the NASDAQ.

READ MORE
Ceo Of Emmac Antonio Costanzo Assesses The Company's SPAC Merger

Ceo Of Emmac Antonio Costanzo Assesses The Company's SPAC Merger

(Video)

READ MORE
European Cannabis Company EMMAC Life Sciences To Go Public On Nasdaq

European Cannabis Company EMMAC Life Sciences To Go Public On Nasdaq

EMMAC Life Sciences, one of Europe’s largest cannabis companies, announced its plans to go public in the U.S. It will list on the Nasdaq exchange through a merger with Andina Acquisition Corp. III. EMMAC shareholders expect to collectively own a majority stake in the combined public company. EMMAC’s Chairman Lorne Abony, CEO Antonio Costanzo, CFO Thomas Ellen, and COO Tom Rooke, will continue to lead the combined entity.

READ MORE